Gorakh Nath Formulations Private Limited

Gorakh Nath Formulations Private Limited - pharma in Meerut, Uttar Pradesh, India. FY 2026 financials & compliance.
CIN U24233UP2011PTC043224 Incorporated 18 January 2011 ROC Kanpur HQ Meerut, Uttar Pradesh, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2024
₹89.91 Cr
▼ 3% YoY
Net profit · FY 2024
₹1.92 Cr
Net margin 2.1%
EBITDA · FY 2024
₹4.97 Cr
EBITDA margin 5.5%
Authorised capital
₹1.5 Cr
Registered with MCA
Paid-up capital
₹1.21 Cr
Issued & subscribed
Open charges
₹16.91 Cr
Satisfied ₹9.35 Cr
Company age
15 yrs
Est. 2011
Directors on board
3
As per MCA filings

About Gorakh Nath Formulations Private Limited

Data last updated:

Gorakh Nath Formulations Private Limited is a private limited company based in Meerut, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 January 2011 and has been in existence for over 15 years.

The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24233UP2011PTC043224. Its GSTIN is 09AAECG0881E1ZP (Uttar Pradesh). The company holds 3 GST registrations, of which 2 are active.

The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.21 Cr. It is led by directors including Brij Mohan and Saransh Agarwal.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Vasu Farm House Khasra No. 93 Sundra (Puttha) Ved Vyas Puri Delhi By Pass, Meerut, Uttar Pradesh, India – 250103.

As per the financials filed for FY 2024, the company reported a revenue of ₹89.91 Cr, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹1.92 Cr (net margin 2.1%) and EBITDA of ₹4.97 Cr (EBITDA margin 5.5%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years and 15% over five years.

As per MCA filings, the company has open charges of ₹16.91 Cr and satisfied charges of ₹9.35 Cr on record. The company has 8 deals on record (5 secondary share transfers, 3 funding rounds), with disclosed funding of ₹1.98 Cr; the latest was in March 2017. Its 6 peer companies in the Chemicals industry (Formulations, Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 1 larger and 5 smaller; the largest is Himachal Polyolefins Limited with revenue of ₹91.05 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 17 overdue payments to 12 micro and small suppliers.

Gorakh Nath Formulations Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-56-0004674). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24233UP2011PTC043224
Registration Number 043224
Incorporation Date 18 January 2011
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UP-56-0004674

Recognitions & Rankings of Gorakh Nath Formulations

MSME (Udyam registered) Ministry of MSME
Category
Small (2022-23)
Udyam number
UDYAM-UP-56-0004674

Contact details

Gorakh Nath Formulations Private Limited's registered office is in Meerut, Uttar Pradesh. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Vasu Farm House Khasra No. 93 Sundra (Puttha) Ved Vyas Puri Delhi By Pass, Meerut, Uttar Pradesh, India – 250103
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Gorakh Nath Formulations Private Limited, buy the company report.

Comprehensive company report
Gorakh Nath Formulations Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Gorakh Nath Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Gorakh Nath Formulations Private Limited, buy the company report.

Financials of Gorakh Nath Formulations Private Limited

FY 2025 filings available

Gorakh Nath Formulations Private Limited reported revenue of ₹89.91 Cr (down 3% YoY) for FY 2024.

Revenue · FY 2024
₹89.91 Cr ▼ 3%
Net profit · FY 2024
₹1.92 Cr margin 2.1%
EBITDA · FY 2024
₹4.97 Cr margin 5.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 3%
3 years · compounded
▲ 26%
5 years · compounded
▲ 15%
EBITDA CAGR growth
3 years · compounded
▲ 16%
5 years · compounded
▲ 16%

Revenue fell 3% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 15%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹4.97 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.92 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin5.5%
Net Profit Margin2.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Gorakh Nath Formulations Private Limited, buy the company report.

Board of directors of Gorakh Nath Formulations Private Limited

Gorakh Nath Formulations has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Brij MohanDirector15 Jul 201115 Years 3 MonthsCurrent
Saransh AgarwalDirector19 Apr 20188 Years 6 MonthsCurrent
Amit GuptaDirector15 Jul 201115 Years 3 MonthsCurrent

Peer comparison

Gorakh Nath Formulations Private Limited is compared with the 6 companies closest to it by revenue in the Chemicals industry (Formulations, Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Himachal Polyolefins Limited₹91.05 Cr (FY 2025)30.0%Sirmaur, Himachal Pradesh, India
Gorakh Nath Formulations Private Limitedthis company₹89.91 Cr (FY 2024)₹1.92 Cr2.1%-3.0%Meerut, Uttar Pradesh, India
Agog Pharma Limited₹89.88 Cr (FY 2024)-7.0%Mumbai, Maharashtra, India
Kunal Conchem Private Limited₹89.71 Cr (FY 2025)-25.0%New Delhi, Delhi, India
Alcedo Pharmachem Private Limited₹89.55 Cr (FY 2025)26.0%Hyderabad, Telangana, India
Shrey Nutraceuticals and Herbals Private Limited₹89.53 Cr (FY 2025)263.0%New Delhi, Delhi, India
Verdant Life Sciences Private Limited₹89.48 Cr (FY 2025)6.0%Andhra Pradesh, India

To see the full peer comparison of Gorakh Nath Formulations Private Limited, buy the company report.

Auditor

Gorakh Nath Formulations Private Limited is audited by SANJAY & CO for the financial year 2023.

Auditor firmFinancial yearFirm registration number
SANJAY & COFY 2023005135C

Shareholding

The shareholding of Gorakh Nath Formulations Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Gorakh Nath Formulations Private Limited, buy the company report.

Charges & borrowings

Open charges
₹16.91 Cr
Satisfied charges
₹9.35 Cr
Breakdown by lending institutions
Others₹15.36 Cr
Axis Bank Limited₹1.15 Cr
Punjab National Bank₹0.40 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
27 Jan 2023100683777Others₹1.5 CrOpen
20 Jan 2022100542869Others₹2 CrOpen
22 Dec 2020100402812Axis Bank Limited₹1.15 CrOpen
04 Jun 2020100365616Others₹79.8 LakhOpen
08 May 2020100337790Others₹40 LakhOpen

To see the full charge records of Gorakh Nath Formulations Private Limited, buy the company report.

Total charge records: 12 View all charges

Deals & funding

Gorakh Nath Formulations Private Limited has 8 deals on record (5 secondary share transfers, 3 funding rounds), with disclosed funding of ₹1.98 Cr; the latest was in March 2017.

Total deals
8
Secondary share transfers
5
Funding rounds
3
Disclosed funding
₹1.98 Cr

Deals on record (5 of 8)

WhenDealAmountParties
Mar 2017Secondary share transferUndisclosedBuyer: an individual
Seller: R S Gupta & Sons, 3 individuals
Mar 2016Secondary share transferUndisclosedBuyer: 2 individuals
Seller: 2 individuals
Mar 2015Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Jul 2014Funding round₹73 LakhInvestors: an individual
Mar 2014Funding round₹38.8 LakhInvestors: 4 individuals

To see the full deal history of Gorakh Nath Formulations Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Gorakh Nath Formulations Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 17 overdue payments to 12 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 12)

SupplierAmount dueDue sinceReported on
an individual supplier
an individual supplier
an individual supplier
an individual supplier
an individual supplier

To see the full MSME payment records of Gorakh Nath Formulations Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

GST

Gorakh Nath Formulations has 3 GST registrations: 2 active and 1 cancelled or inactive.

Total GSTINs
3
Active
2
Cancelled / inactive
1
GSTINStateStatusRegistered on
09AAECG0881E1ZPUttar PradeshActive01 Jul 2017
10AAECG0881E1Z6BiharActive01 Jul 2017

To see the full GST registrations and return filing status of Gorakh Nath Formulations Private Limited, buy the company report.

Recent activity

Gorakh Nath Formulations Private Limited has 10 board changes on record since 2011: 3 appointments and 7 cessations. The latest: Saransh Agarwal ceased to be Additional Director on 30 Nov 2021.

AGM
Gorakh Nath Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Gorakh Nath Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Charges
A charge registered on 11 Aug 2020 via Charge ID 100359914 with Others was fully satisfied on 04 Jul 2024.
Charges
A charge registered on 11 Feb 2020 via Charge ID 100326750 with Others was fully satisfied on 03 Mar 2023.
Charges
A charge with Others amounted to Rs. 1.50 Cr with Charge ID 100683777 was registered on 27 Jan 2023.
Charges
A charge with Others of Rs. 8.50 Cr registered on 19 Jan 2012 with Charge ID 10337175 was modified on 27 Jan 2023.
Charges
A charge with Others amounted to Rs. 2.00 Cr with Charge ID 100542869 was registered on 20 Jan 2022.
Ceased
Saransh Agarwal ceased to be Additional Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 1.15 Cr with Charge ID 100402812 was registered on 22 Dec 2020.
Charges
A charge with Others amounted to Rs. 2.30 Cr with Charge ID 100359914 was registered on 11 Aug 2020.
Charges
A charge with Others amounted to Rs. 0.80 Cr with Charge ID 100365616 was registered on 04 Jun 2020.
Charges
A charge with Others amounted to Rs. 0.40 Cr with Charge ID 100337790 was registered on 08 May 2020.

17 earlier events are in the company report.

Frequently asked questions

Gorakh Nath Formulations is an active private limited company based in Meerut, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 January 2011 (15+ years old) and is registered under CIN U24233UP2011PTC043224.

Gorakh Nath Formulations has 3 current directors:

The latest financial statements of Gorakh Nath Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Gorakh Nath Formulations is 09AAECG0881E1ZP, registered in Uttar Pradesh. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 10AAECG0881E1Z6 (Bihar).

The CIN (Corporate Identification Number) of Gorakh Nath Formulations is U24233UP2011PTC043224. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Gorakh Nath Formulations was incorporated on 18 January 2011, making it 15+ years old. It is registered with the Registrar of Companies, Kanpur.

Gorakh Nath Formulations has 8 deals on record (5 secondary share transfers, 3 funding rounds), with disclosed funding of ₹1.98 Cr; the latest was in March 2017.

The peers of Gorakh Nath Formulations by revenue are Himachal Polyolefins Limited, Agog Pharma Limited, Kunal Conchem Private Limited, Alcedo Pharmachem Private Limited, Shrey Nutraceuticals and Herbals Private Limited and 1 more, all in the Chemicals industry (Formulations, Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Saransh Agarwal ceased to be Additional Director on 30 Nov 2021. Shantanu Agarwal ceased to be Director on 23 Jun 2018. Saransh Agarwal was appointed as Director on 19 Apr 2018. Gorakh Nath Formulations has 10 board changes on record in total.

Yes, Gorakh Nath Formulations is registered as a small enterprise under Udyam registration (number: UDYAM-UP-56-0004674).

Gorakh Nath Formulations has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 17 overdue payments to 12 micro and small suppliers. The latest return was filed on 30 May 2019.

The registered office of Gorakh Nath Formulations is at Vasu Farm House Khasra No. 93 Sundra Puttha Ved Vyas Puri Delhi By Pass, Meerut, Uttar Pradesh, India – 250103.